- Home
- AGRZ
AGRZ
Agroz Inc. Ordinary Shares
as 10-07-2025 3:30pm EST
| Founded: | 2020 | Country: | Malaysia |
| Employees: | N/A | City: | N/A |
| Market Cap: | 56.6M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 553.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.04 | EPS Growth: | -6.60 |
| 52 Week Low/High: | $2.52 - $5.13 | Next Earning Date: | 01-01-0001 |
| Revenue: | $9,138,479 | Revenue Growth: | 121.21% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Agroz Inc. Ordinary Shares News
AGRZ Breaking Stock News: Dive into AGRZ Ticker-Specific Updates for Smart Investing
Just Food
2 days ago
Clarebout Potatoes’ staff strike over bonuses linked to JR Simplot takeover
Business Wire
2 days ago
Diamond Chemical Announces Appointment of New CEO
Insider Monkey
2 days ago
Is this the Best Time to Add Parker-Hannifin (PH)?
CNW Group
2 days ago
FSRA issues Notice of Proposal against Daumier Financial Services Inc. o/a Daumier Financial Services Ltd., Carlos Daumier De Zayas Benitez, and Liset Jimenez Rodriguez
MT Newswires
2 days ago
UBS Adjusts Price Target on Chemours to $21 From $17, Maintains Buy Rating
Euronews
2 days ago
‘When people buy an EV, they rarely go back’: Hyundai CEO on designing for Europe
MT Newswires
2 days ago
UBS Adjusts Price Target on Graphic Packaging Holding to $20 From $24, Maintains Neutral Rating
MT Newswires
2 days ago
UBS Adjusts Price Target on Ecolab to $299 From $295, Maintains Neutral Rating
Compare AGRZ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AGRZ Agroz Inc. Ordinary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.